Moderna shares down after pulling Covid-flu combo vaccine application
After the FDA asked for more clinical data in May 2025, Moderna has decided to resubmit the BLA later this year.
After the FDA asked for more clinical data in May 2025, Moderna has decided to resubmit the BLA later this year.
What's Your Reaction?
